BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 19882519)

  • 1. Efficacy of 2% ibopamine on the dilation of patients with pseudoexfoliation syndrome.
    Scuderi GL; Regine F; Perdicchi A; Turtoro A; Contestabile MT
    Eur J Ophthalmol; 2010; 20(1):120-3. PubMed ID: 19882519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of the effects of 2% ibopamine, 10% phenylephrine, and 1% tropicamide on the anterior segment.
    Marchini G; Babighian S; Tosi R; Perfetti S; Bonomi L
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):281-9. PubMed ID: 12506086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ibopamine on aqueous humor production in normotensive humans.
    McLaren JW; Herman DC; Brubaker RF; Nau CB; Wayman LL; Ciarniello MG; Rosignoli MT; Dionisio P
    Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4853-8. PubMed ID: 14578408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Pupillary Dilation on Intraocular Pressure and Anterior Segment Morphology in Subjects with and without Pseudoexfoliation.
    Atalay E; Tamçelik N; Cicik ME
    Curr Eye Res; 2015 May; 40(6):646-52. PubMed ID: 25197765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pupillographic evaluation of the mydriatic effect of ibopamine solution.
    Gelmi C; Palazzuolo A; Lucchetti M; Trimarchi F
    Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):346-51. PubMed ID: 2777423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of 2% ibopamine eye drops on the intraocular pressure and pupil motility of patients with open-angle glaucoma.
    Giuffrè I; Taverniti L; Di Staso S
    Eur J Ophthalmol; 2004; 14(6):508-13. PubMed ID: 15638100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of mydriatics on intraocular pressure and pupil size in the normal feline eye.
    Stadtbäumer K; Frommlet F; Nell B
    Vet Ophthalmol; 2006; 9(4):233-7. PubMed ID: 16771758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre- versus post-dilation changes in intraocular pressure: their clinical significance.
    Qian CX; Duperré J; Hassanaly S; Harissi-Dagher M
    Can J Ophthalmol; 2012 Oct; 47(5):448-52. PubMed ID: 23036547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mydriatic and cardiovascular effects of phenylephrine 2.5% versus phenylephrine 10%, both associated with tropicamide 1%.
    Motta MM; Coblentz J; Fernandes BF; Burnier MN
    Ophthalmic Res; 2009; 42(2):87-9. PubMed ID: 19478547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pupil dilation using drops vs gel: a comparative study.
    Moisseiev E; Loberman D; Zunz E; Kesler A; Loewenstein A; Mandelblum J
    Eye (Lond); 2015 Jun; 29(6):815-9. PubMed ID: 25857606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pupil dilation using phenylephrine alone or in combination with tropicamide.
    Eyeson-Annan ML; Hirst LW; Battistutta D; Green A
    Ophthalmology; 1998 Apr; 105(4):726-32. PubMed ID: 9544648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combination solution for routine pupillary dilation.
    Krumholz DM; Portello JK; Rosenfield M; Rosenbaum JD
    Optometry; 2006 Jul; 77(7):350-3. PubMed ID: 16814239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of mydriatic eye drops on wavefront sensing with the Zywave aberrometer.
    Taneri S; Oehler S; Azar DT
    J Refract Surg; 2011 Sep; 27(9):678-85. PubMed ID: 21446641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a new preoperative ophthalmic solution.
    Hirowatari T; Tokuda K; Kamei Y; Miyazaki Y; Matsubara M
    Can J Ophthalmol; 2005 Feb; 40(1):58-62. PubMed ID: 15825531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Same-eye comparison of pupillary dilation with an intraoperative standardized intracameral combination of mydriatics (Mydrane®) versus a preoperative ophthalmic (Mydriasert®) in standard cataract surgery in non-diabetic patients (French translation of the article)].
    de Faria A; Giorgi R; Cohen Salmon M; Bonnel S; Holweck G; Le Corre A; Chazalon E
    J Fr Ophtalmol; 2019 Dec; 42(10):1068-1077. PubMed ID: 31668379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed intraocular pressure elevation after pupillary dilation in exfoliation syndrome.
    Shihadeh WA; Ritch R; Scharf B; Liebmann JM
    Acta Ophthalmol; 2011 Sep; 89(6):560-2. PubMed ID: 19878115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of efficacy and tolerance between 1% hydroxyamphetamine plus 0.25% tropicamide (Paremyd) and 0.5% tropicamide combined with 2.5% phenylephrine.
    Zeise MM; McDougall BW; Bartlett JD; Corliss D; Mitten L
    J Am Optom Assoc; 1996 Nov; 67(11):681-9. PubMed ID: 8979662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of 5% phenylephrine and 0.5% tropicamide eyedrops for pupil dilation in neonates is twice as effective as 0.5% tropicamide eyedrops alone.
    Lux AL; Degoumois A; Barjol A; Mouriaux F; Denion E
    Acta Ophthalmol; 2017 Mar; 95(2):165-169. PubMed ID: 27519933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ibopamine: a new preoperative mydriatic for cataract surgery.
    Corbett MC; Buckley SA; Richards AB
    Eur J Ophthalmol; 1994; 4(1):29-34. PubMed ID: 7912576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single dose of 1% tropicamide and 10% phenylephrine for pupil dilation.
    Ratanapakorn T; Yospaiboon Y; Chaisrisawadsuk N
    J Med Assoc Thai; 2006 Nov; 89(11):1934-9. PubMed ID: 17205877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.